COVID-19 ARDS in two patients with left ventricular assist device.
Mustafa Mert ÖzgürHakan HançerÖzge AltaşKaan KıraliPublished in: Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs (2021)
Coronavirus disease 2019 affected millions of people and caused pneumonia, acute respiratory distress syndrome and increased mortality worldwide. Data from multicenter studies showed that concomitant chronic diseases are associated with severe coronavirus disease. Patients with left ventricular assist device (LVAD) support may also be vulnerable to the disease. Some symptoms of COVID-19 infection like dyspnea and fatigue can overlap with heart failure or LVAD dysfunction. Careful evaluation should be made to diagnose and treat these patients. In these two cases with COVID-19, here we presented the first two patients supported with LVAD in Turkey.
Keyphrases
- coronavirus disease
- left ventricular assist device
- acute respiratory distress syndrome
- end stage renal disease
- heart failure
- ejection fraction
- sars cov
- extracorporeal membrane oxygenation
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- type diabetes
- prognostic factors
- mechanical ventilation
- oxidative stress
- patient reported outcomes
- risk factors
- sleep quality
- depressive symptoms
- respiratory failure
- acute heart failure